PinnedGaston WelischinThe Curious ResearchersAI Oracles: Reimagining the Role of Creative Practitioners in the Age of Generative AI ToolsThe Oracle of Delphi guided the Greeks through their most perplexing dilemmas. When uncertainty loomed, people turned to the oracles…Apr 13, 2023Apr 13, 2023
PinnedGaston WelischinThe Curious ResearchersPostcard to a ghost: Dr. Marie Skłodowska-Curie to Dr. Anja B. SmykowskiHi and welcome. I am Gaston Welisch and I am the editor for a new series of speculative and experimental articles called ‘Postcards to a…Feb 17, 2023Feb 17, 2023
Gaston WelischinThe Curious ResearchersCooking up a workshop: The analogical framework and a curricular menuA Recipe for Success Through a Delicious Curriculum Crafting ApproachOct 19, 2023Oct 19, 2023
Gaston WelischinThe Curious ResearchersWhat I Learned from Building 3 AI Apps in 3 Months: The Unexpected, the Emotional and the EthicalIn the past three months, I set myself a challenge to build three AI apps, each with its own purpose and lessons to be learnt. It was a…Oct 6, 2023Oct 6, 2023
Gaston WelischinThe Curious ResearchersData Poets: AI and the Poetics of SpaceIn AI as with most technologies, time can bring both change and perspective. Since 2020, AI has gone from a tool of intrigue and…Jul 13, 2023Jul 13, 2023
Gaston WelischinThe Curious ResearchersPostcard to a ghost: Miles Davis to Prof. Nicol KeithMiles Davis is one of the most influential figures in jazz and indeed 20th century music. His life and works are widely covered including…Mar 29, 2023Mar 29, 2023
Gaston WelischinThe Curious ResearchersFirst in Human — Part 5: Learning from treating childhood cancer.By Gaston Welisch & Nicol KeithJan 18, 2023Jan 18, 2023
Gaston WelischinThe Curious ResearchersFirst in Human — Part 4: Networks and Stakeholders in Cancer Trials.By Gaston Welisch & Nicol KeithJan 4, 2023Jan 4, 2023
Gaston WelischinThe Curious ResearchersFirst in Human — Part 3: Who makes a Cancer Phase 1 Trial happen?By Gaston Welisch & Nicol KeithDec 13, 20221Dec 13, 20221
Gaston WelischinThe Curious ResearchersFirst in Human — Part 2: The Importance of Cancer Phase 1 Trials.By Gaston Welisch & Nicol KeithNov 29, 2022Nov 29, 2022